These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15207248)

  • 21. Dysfunctional vasa vasorum in diabetic peripheral artery obstructive disease with critical lower limb ischaemia.
    Orrico C; Pasquinelli G; Foroni L; Muscarà D; Tazzari PL; Ricci F; Buzzi M; Baldi E; Muccini N; Gargiulo M; Stella A
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):365-74. PubMed ID: 20570185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F; Jehle PM; Jung MF; Boehm BO; Brueckel J; Hombach V; Osterhues HH
    Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated VEGF-plasma levels in young patients with mild essential hypertension.
    Stumpf C; Jukic J; Yilmaz A; Raaz D; Schmieder RE; Daniel WG; Garlichs CD
    Eur J Clin Invest; 2009 Jan; 39(1):31-6. PubMed ID: 19067736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging.
    Di Bonito P; Moio N; Cavuto L; Covino G; Murena E; Scilla C; Turco S; Capaldo B; Sibilio G
    Diabet Med; 2005 Dec; 22(12):1720-5. PubMed ID: 16401318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Response to metoprolol succinate sustained-release tablets in correlation to pulse pressure, serum vascular endothelial growth factor and C-reactive protein in elderly hypertensive patients with chronic heart failure].
    Zhang ZW; Lin ZP
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2171-4. PubMed ID: 20855282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of VEGF polymorphisms on the severity of peripheral artery disease in diabetic patients.
    Bleda S; De Haro J; Varela C; Esparza L; De Maturana IL; Acin F
    Growth Factors; 2012 Oct; 30(5):277-82. PubMed ID: 22762535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
    Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease.
    Guo L; Jiang F; Tang YT; Si MY; Jiao XY
    Diabetes Technol Ther; 2014 Apr; 16(4):224-34. PubMed ID: 24279470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
    Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
    Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin.
    Yilmaz MI; Saglam M; Qureshi AR; Carrero JJ; Caglar K; Eyileten T; Sonmez A; Cakir E; Oguz Y; Vural A; Yenicesu M; Stenvinkel P; Lindholm B; Axelsson J
    Nephrol Dial Transplant; 2008 May; 23(5):1621-7. PubMed ID: 18175782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease.
    Zygalaki E; Kaklamanis L; Nikolaou NI; Kyrzopoulos S; Houri M; Kyriakides Z; Lianidou ES; Kremastinos DT
    Clin Biochem; 2008 Jan; 41(1-2):82-7. PubMed ID: 17961532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.
    Byon IS; Jeon HS; Kim HW; Lee SJ; Lee JE; Oum BS
    Curr Eye Res; 2013 Jul; 38(7):774-80. PubMed ID: 23725216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium and angiogenesis in white coat hypertension.
    Karter Y; Aydin S; Curgunlu A; Uzun H; Ertürk N; Vehid S; Kutlu A; Simsek G; Yücel R; Arat A; Ozturk E; Erdine S
    J Hum Hypertens; 2004 Nov; 18(11):809-14. PubMed ID: 15215878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients.
    Ferroni P; Martini F; D'Alessandro R; Magnapera A; Raparelli V; Scarno A; Davì G; Basili S; Guadagni F
    Clin Chim Acta; 2008 Feb; 388(1-2):33-7. PubMed ID: 18001701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus.
    Nomura S; Shouzu A; Omoto S; Nishikawa M; Fukuhara S; Iwasaka T
    Thromb Res; 2006; 117(4):385-92. PubMed ID: 15896827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.